Monkeypox: is topical cidofovir a good idea?
Clin Exp Dermatol
.
2023 Feb 2;48(2):132-134.
doi: 10.1093/ced/llac038.
Authors
Carmen Alejandra Rubio-Muniz
1
,
Julia Montero-Menárguez
1
,
Alba López-Valle
1
,
Manuel Agud-Dios
1
,
Jorge Arroyo-Andrés
1
,
José Luis Rodriguez-Peralto
2
,
Sara Isabel Palencia-Pérez
1
,
Eloy José Tarín-Vicente
1
Affiliations
1
Departments of Dermatology and Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.
2
Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.
PMID:
36730511
DOI:
10.1093/ced/llac038
No abstract available
MeSH terms
Administration, Topical
Antiviral Agents / therapeutic use
Cidofovir / therapeutic use
Humans
Mpox (monkeypox)* / drug therapy
Substances
Cidofovir
Antiviral Agents